Australia markets open in 7 hours 18 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0950-0.1650 (-5.06%)
As of 10:42AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
51,333
39,986
31,432
21,193
Cost of revenue
12,475
9,940
12,237
7,060
Gross profit
38,858
30,046
19,195
14,133
Operating expenses
Research development
181,820
111,340
106,879
76,963
Selling general and administrative
183,428
116,179
103,557
63,638
Total operating expenses
369,388
231,572
214,377
143,610
Operating income or loss
-330,530
-201,526
-195,182
-129,477
Interest expense
9,799
20,181
36,139
57,631
Total other income/expenses net
-17,223
-88,897
-129,346
-27,594
Income before tax
-357,528
-310,580
-359,576
-213,781
Income tax expense
-425
-2,014
-473
-6,274
Income from continuing operations
-357,403
-314,410
-363,012
-212,526
Net income
-355,410
-298,461
-292,068
-203,540
Net income available to common shareholders
-355,410
-298,461
-292,068
-203,540
Basic EPS
-
-1.30
-2.20
-1.92
Diluted EPS
-
-1.30
-2.35
-1.92
Basic average shares
-
229,823
132,732
106,150
Diluted average shares
-
229,823
140,514
106,150
EBITDA
-
-279,392
-312,448
-147,096